Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alternative Medical Enterprises, commonly known as AltMed, is a fully integrated medical cannabis company that focuses on the research, development, and commercialization of pharmaceutical-grade cannabis products. Operating primarily through its MÜV brand, the company utilizes advanced extraction and formulation technologies to produce a wide range of delivery formats, including transdermal patches, metered-dose inhalers, and topical creams. In 2021, AltMed completed a major merger with Verano Holdings, significantly expanding its cultivation and retail footprint across the United States. The company is recognized for its commitment to scientific standards and medical-grade consistency in the legal cannabis industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alternative Medical Enterprises.